The CpG island methylator phenotype defines an immune-cold and therapy-resistant subtype of cutaneous melanoma - Top-Institutions - MDSpire

The CpG island methylator phenotype defines an immune-cold and therapy-resistant subtype of cutaneous melanoma

  • By

  • Wei Lu

  • Xiaowei Sha

  • Hua Lei

  • Chong Mao

  • June 24, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The Cancer Genome Atlas
    The Cancer Genome Atlas

    N/A, N/A

    Key Differentiators

    • Dermatology

  • #2

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Dermatology

  • #3

    Center for Cancer Immune Therapy, Herlev Hospital
    Center for Cancer Immune Therapy, Herlev Hospital

    Herlev, Denmark

    Key Differentiators

    • Dermatology

  • #4

    Herlev and Gentofte Hospital Research Council
    Herlev and Gentofte Hospital Research Council

    Herlev, Denmark

    Key Differentiators

    • Dermatology

  • #5

    The Wistar Institute
    The Wistar Institute

    Philadelphia, PA

    Key Differentiators

    • Dermatology

Original Source(s)

The CpG island methylator phenotype defines an immune-cold and therapy-resistant subtype of cutaneous melanoma

  • by Wei Lu, Xiaowei Sha, Hua Lei, Chong Mao

  • June 24, 2026

Related Content

Severe asparaginase-associated hypertriglyceridemia in pediatric acute lymphoblastic leukemia: a single-center experience

Mucosal-associated invariant T cells promote PDAC progression via TL1A–CSF-1 axis

A New Cancer Diagnosis is Never Good—Patient Choice, Busy Health Systems, and Health Information Access :